Sen. Charles Grassley (R-IA) asked eight medical journals to provide information about their ghostwriting practices and policies. He said the letter is part of an effort to “shed light on the role [pharmaceutical] companies may play in the dissemination of information about their products through medical literature.”
http://grassley.senate.gov/